Ongoing Unicycive Therapeutics, Inc. (UNCY) Investigation: Protect Your Rights – Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc.") (NASDAQ:UNCY) concerning possible violations of federal securities laws. On June 30, 2025, Unicycive "announced that the U.S. Food and Drug Administration (FDA) has issued a CRL […]